ImmunityBio
IBRX
$5.83
Share price
-2.18%
Change (1 day)
112.77%
Change (1 year)
Categories
ImmunityBio (IBRX) - Total assets
Total assets on the balance sheet as of March 2024 : $0.40 B
According to ImmunityBio's latest financial reports the company's total assets are $0.40 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ImmunityBio - Total assets on balance sheet (from 2020 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.36 B | -22.72% |
| 2021-12-31 | $0.46 B | 111.81% |
| 2020-12-31 | $0.22 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.35 B | -12.45% | 🇺🇸 USA |